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Abstract
Influenza viruses continuously undergo antigenic changes with gradual accumulation of mutations in hemagglutinin (HA)
that is a major determinant in subtype specificity. The identification of conserved epitopes within specific HA subtypes gives
an important clue for developing new vaccines and diagnostics. We produced and characterized nine monoclonal
antibodies that showed significant neutralizing activities against H1 subtype influenza viruses, and determined the complex
structure of HA derived from a 2009 pandemic virus A/Korea/01/2009 (KR01) and the Fab fragment from H1-specific
monoclonal antibody GC0587. The overall structure of the complex was essentially identical to the previously determined
KR01 HA-Fab0757 complex structure. Both Fab0587 and Fab0757 recognize readily accessible head regions of HA, revealing
broadly shared and conserved antigenic determinants among H1 subtypes. The b-strands constituted by Ser110-Glu115 and
Lys169-Lys170 form H1 epitopes with distinct conformations from those of H1 and H3 HA sites. In particular, Glu112, Glu115,
Lys169, and Lys171 that are highly conserved among H1 subtype HAs have close contacts with HCDR3 and LCDR3. The
differences between Fab0587 and Fab0757 complexes reside mainly in HCDR3 and LCDR3, providing distinct antigenic
determinants specific for 1918 pdm influenza strain. Our results demonstrate a potential key neutralizing epitope important
for H1 subtype specificity in influenza virus.
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Introduction
Influenza is a viral infectious disease of the respiratory tract that
affects millions of people annually [1]. Combined with subsequent
infection from bacterial pneumonia, influenza remains one of the
leading causes of death in many countries [2]. The 1918 influenza
pandemic (pdm) killed 40–50 million people worldwide [3] and the
2009 pdm influenza that was identified in 214 countries caused
more than 18,000 deaths worldwide, despite global influenza
preparedness [4].
Influenza viruses which belong to the family of Orthomyxoviridae
have three antigenically distinct types of virus, A, B, and C [5,6].
Influenza A viruses contain three surface proteins: hemagglutinin
(HA), neuraminidase (NA), and a proton channel M2 [7,8]. The
viruses are divided into subtypes on the basis of differences in the
antigenicity of HA and NA. After the recent discovery of a new
subtype virus genome identified from bat, there are currently 17
HA subtypes (H1–H17) and 10 NA subtypes (N1–N10) known
[9,10]. Influenza A viruses with three HA (H1, H2 and H3) and
two NA (N1 and N2) serotypes have adapted to humans to
produce H1N1 pdm in 1918 and 2009, H2N2 pdm in 1957, and
H3N2 pdm in 1968 [11–13].
The 2009 pdm viruses were derived from a reassortment of six
gene segments from triple reassortant swine virus and two gene
segments from Eurasian influenza A (H1N1) swine virus lineage
[13]. Amino acid sequence identity between 2009 pdm HA and
those derived from previous vaccine strains such as A/Brisbane/
59/07 (H1N1) and A/Solomon Islands/3/2006 (H1N1) reaches
approximately 80%, which drops to 35–40% within the antigenic
sites. It was shown that the antigenic and glycosylation patterns of
2009 pdm HA are rather similar to those of 1918 pdm HA,
showing 20% amino acid difference in the antigenic sites [14].
HA is synthesized as a precursor, HA0, that trimerizes in the
endoplasmic reticulum and is transferred through the Golgi
apparatus to the cell surface [15–17]. Cleavage of the precursor
HA into the subunits HA1 and HA2 by a cellular protease is
required for viral infectivity [18,19]. The HA2 stem region,
proximal to the viral membrane, is highly conserved across strains
and among most subtypes. Since the first cross-neutralizing
antibody against influenza virus was reported [20], many
structures of broadly neutralizing antibodies in complex with
HA proteins have been determined [21–24]. Several studies also
reported the existence of HA subtype-specific and inter subtype-
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conserved epitopes [25–27]. However, immune specific epitopes in
H1N1 influenza virus have not been completely assessed.
During the production of H1-specific monoclonal antibodies
against 2009 pdm H1N1 strains, we isolated and characterized
nine H1-specific monoclonal antibodies which neutralized a broad
range of H1 subtype influenza viruses. Among them, we
determined the structure of the HA protein from a 2009 pandemic
virus A/Korea/01/2009 (KR01) in complex with the Fab
fragment from GC0587 and compared with the KR01 HA-
Fab757 complex structure. In addition to GC0587, GC0757
exhibits additional activity against A/Brevig Mission/1/1918. The
structural features of the complexes provide a understanding of
how antibodies with subtype specificity can distinguish antigenic
determinants.
Results
In vivo Production and in vitro Characterization of
Monoclonal Antibodies
In our initial immunogenicity experiment, A/California/07/
2009 (CA07) was used to immunize groups of BALB/c mice and
antibody-producing cells were screened by ELISA for secretion of
antibodies. Nine monoclonal antibodies were then tested for
neutralization against a panel of 14 isolates including H1,
2009 pdm H1, H2, H3, H5, and H7 (Table 1). Among them,
four monoclonal antibodies GC0587, GC0757, GC1517, and
GC1761 were shown to neutralize a broad range of H1 subtype
influenza A viruses including 2009 pdm isolates. GC0587,
GC0757 and GC1517 exhibited significant neutralizing activity
against 2009 pdm H1N1 strains and a seasonal H1N1 strain,
whereas GC0757, GC1517 and GC1761 showed the activity
against A/Brevig Mission/1/1918.
Examination based on ELISA assays for the antigenicity against
KR01 HA revealed that GC0346, GC0587, GC0757, and
GC1517 had significantly high affinity to HA (Fig. 1), whereas
GC0352, GC1245, GC1289, GC1747, and GC1761 showed
moderate or little affinity even at high concentrations. In
particular, GC0587 and GC0757 showed high affinity binding
to HAs derived from both KR01 and CU44 strains and their Fab
fragments were found to bind to HAs derived from H1 subtype
viruses with high affinities (Kd 2.5–8.9 nM). The dissociation
constants were within the range typically required for effective
neutralization, comparable to stem binding antibodies (Kd
,10 nM) [21]. In order to study broad antigenicity among H1
subtype strains, we selected four antibodies GC0346, GC0587,
GC0757, and GC1517 and attempted to crystallize their Fab
fragments in complex with KR01 HA. Our attempt yielded
crystals derived from antibodies GC0587 or GC0757 only,
suitable for X-ray structural determination.
Overall Structure of the KR01 HA-Fab0587 Complex
The purified recombinant KR01 HA was monomeric in
solution. The structure from small rhombic crystals
(0.0260.0260.05 mm) of KR01 HA-Fab0587 complex was
determined at 3.1 A˚ resolution (Table 2). The asymmetric unit
of the crystal contained four copies of HA-Fab0587 complexes,
where Fab binds to the head region of KR01 HA resulting in a
linear arrangement of the complex consisting of one Fab, two head
regions of HA, and another Fab molecule (Fig. 2A). The HA-
Fab0587 complex structure revealed head-to-head arrangement of
HA as shown in KR01 HA (PDB ID: 4EDA) and the HA-Fab0757
complex (r.m.s.d. was 1.3 A˚), to which the longitudinal axis of Fab
in the complex was parallel. The overall arrangement of HA and
Fab0587 was thus very similar to that of the HA-Fab0757 complex
structure [28]. Superposition of the two complex structures yielded
an overall r.m.s.d. of 2.1 A˚, whereas the head or stem regions
superimposed well individually (0.9 and 0.8 A˚ on average,
respectively). The stem region was largely invisible in the electron
density map, for which a partial model could be built, consisting of
residues 414–427 (87–100 of HA2) in loop and a-helical
conformations with high B factors ranging from 54–128 A2. A
possible orientation of the HA2 domain can be derived from this
partial model. When the KR01 HA structure was superimposed to
that of the HA-Fab0587 complex, the head region of KR01 HA
Table 1. In vitro neutralization activity of antibodies against a panel of HA from influenza A viruses.
Antibody HA from Strains* GC 0346 GC 0352 GC 0587 GC 0757 GC 1245 GC 1289 GC 1517 GC 1747 GC 1761
A/Brisbane/59/2007(H1N1) 2 2 ++ ++ 2 2 ++ 2 +
A/California/04/2009(H1N1) ++ + ++ ++ 2 2 ++ 2 ++
A/Brevig Mission/1/1918(H1N1) 2 2 2 ++ 2 2 ++ 2 ++
A/California/07/2009(H1N1) ++ ++ ++ ++ 2 2 ++ 2 ++
A/Japan/305/1957(H2N2) 2 2 2 2 2 2 ++ 2 2
A/Brisbane/10/2007(H3N2) 2 2 2 2 2 2 2 2 2
A/Anhui/1/2005(H5N1) 2 2 2 2 2 2 2 2 2
A/Indonesia/5/2005(H5N1) 2 2 2 2 2 2 2 2 2
A/Viet Nam/1194/2004(H5N1) 2 2 2 2 2 2 2 2 2
A/Viet Nam/1203/2004(H5N1) 2 2 2 2 2 2 2 2 2
A/bar-headed goose/Qinghai/14/2008 (H5N1) 2 2 2 2 2 2 ++ 2 2
A/turkey/Turkey/1/2005(H5N1) 2 2 2 2 2 2 2 2 2
A/Netherlands/219/03(H7N7) 2 2 2 2 2 2 2 2 2
2009 pandemic vaccine ++ ++ ++ ++ ++ ++ ++ + ++
+represents a positive neutralization activity of each antibody determined by ELISA and –represents a negative neutralizing activity.
*A/California/04/2009(H1N1), A/Brisbane/59/2007(H1N1), A/California/04/2009(H1N1), A/Brevig Mission/1/1918(H1N1), A/California/07/2009(H1N1), A/Japan/305/
1957(H2N2), A/Brisbane/10/2007(H3N2), A/Anhui/1/2005(H5N1), A/bar-headed goose/Qinghai/14/2008(H5N1), A/Indonesia/5/2005(H5N1), A/turkey/Turkey/1/
2005(H5N1), A/Viet Nam/1194/2004(H5N1), A/Viet Nam/1203/2004(H5N1), A/Netherlands/219/03(H7N7).
doi:10.1371/journal.pone.0089803.t001
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was found to be rotated clockwise by ,20u relative to the stem
region (Fig. 2B). We observed that there are empty spaces in the
crystal lattice for which the HA2 domain can exist (Figure S1 in
File S1). The conformation of the stem region is known to be
metastable, which is temporarily stabilized by the head region of
capped conformation [29,30]. The conformational changes of HA
that alleviate the constraints imposed in the pre-fusion state are
known to provide the energy that is required to induce membrane
fusion. The KR01 HA-Fab0587 complex structure demonstrates
that the head region of HA molecule is stabilized by antibody
binding and the invisible stem region adopts different orientations
relative to the head region from what we have observed in typical
HA proteins (Fig. 2C).
A conserved H1 Subtype-specific Epitope of HA
The amino acid sequence identity between the variable domains
of GC0587 and GC0757 is 93% in the H-chain and 98% in the L-
chain (Fig. 3A), with the largest difference in HCDR3. The
interface in the HA-Fab complexes was found to consist of
interactions with heavy chain CDRs (HCDRs) 2 and 3 and light
Figure 1. Binding affinities of monoclonal antibodies against H1 HAs. ELISA analysis results of monoclonal antibodies against KR01 and
CU44 HAs that were coated on the 96-well plates to which 0 to 10 mg/ml of antibodies were added. Absorbance was measured after addition of TMB
solution to each well at 490 nm.
doi:10.1371/journal.pone.0089803.g001
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chain CDRs (LCDRs) 1 and 3 (Fig. 3B). A total buried surface
area at the interface in the Fab0587 complex is 1,029 A˚2, of which
48% arise from binding to the H-chain and 52% from the L-chain.
In the Fab0757 complex, it is 993.2 A˚2, with 50% from the H- and
L-chains each. The buried surface areas are in the increasing order
of LCDR1, HCDR2, LCDR3, and HCDR3, ranging from 230 to
300 A˚2. LCDR3 and HCDR3 have the largest number of
interactions in the HA-Fab0587 complex, whereas LCDR3 and
HCDR2 have the largest in the HA-Fab0587 complex (Table S1
in File S1). It is notable that aromatic amino acid residues are
found to contribute to the interactions at the interface between HA
and Fab: Tyr31 of LCDR1, Tyr58 of HCDR2, Tyr99 of LCDR3,
and Tyr103 of HCDR3 interact with residues Thr72, Lys163,
Glu115, and Lys171 of HA, respectively, in both complex
structures (Fig. 3C).
Human k chain LCDR3 is typically nine amino acids long,
whereas HCDR3 lengths range from 6 to 28 amino acids in adults
[31]. HCDR3 and LCDR3 of 6 to 8 residues in length in Fab0587
and Fab0757 represent a short-length CDR, but they contribute
substantially to the interactions with HA molecules (Fig. 3C, inset).
Glu112 and Glu115 have close contacts with the main chain
atoms of Tyr103 and Thr104 in HCDR3 and of Glu96 and Val97
in LCDR3, respectively. The side chain of Glu115 forms a
hydrogen bond with the hydroxyl group of Tyr99. Lys169 and
Lys171 also contribute significantly to the interaction in HCDR3.
These interactions revealed common features at the interface in
Figure 2. Overview of the structures of KR01 HA and its complex with Fab0587. (A) Structure of KR01 HA-Fab0587 complex. HA are colored
in orange and light brown, H-chains are blue and green, and L-chains are light blue and lime. (B) Superposition of KR01 HA in Fab0587 complex and
head domain of KR01 HA structures, and (C) superposition of stem region between Fab0587 bound KR01 HA and Free KR01 HA. Gray color represents
free HA, and orange color represents HA in complex.
doi:10.1371/journal.pone.0089803.g002
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the complex structures. Both Glu112 and Glu115 are highly
conserved in H1 subtype viruses, whereas they are not in other
subtype HA sequences (Fig. 3A and Figure S2 in File S1). In
addition, Pro118, Ser121, Lys163, and Tyr165 in HA that interact
with HCDR2, and Tyr253 that interacts with LCDR3 are highly
conserved in H1 subtype strains. Notably, these residues are found
to be different from those of the known antigenic sites, Sa, Sb, Ca,
and Cb (Fig. 3D). In this context, KR01 HA structures in complex
with GC0587 or GC0757 reveal a distinct epitope in the head
region which was not reported before.
Interactions at the KR01 HA-Fab Complexes
Both GC0587 and GC0757 neutralize a broad range of H1
subtype viruses including 2009 pdm H1N1 and seasonal H1N1
strains, and GC0757 further reacts with 1918 pdm H1N1 (Table 1
and Fig. 1). Despite similar amino acid sequences and common
structural features of the two Fab fragments, a detailed structural
analysis of the HA-Fab0587 complex revealed several epitope
regions distinct from those of the HA-Fab0757 complex. First, the
main chain of HA from Thr72 to Ser74 moves closer to the Fab
fragment in the Fab0587 complex and interacts mostly with
LCDR1 from Asn30 to Ile33 (Figure S3 in File S1). There are
relatively less hydrophilic interactions between HA and LCDR1 in
the Fab0587 complex than other CDRs. Second, the interactions
Table 2. Data and refinement statistics.
Data statistics HA-Fab0587
Wavelength (A˚) 1,0000
Number of reflections
(unique reflections)
230,693 (51,527)
Resolution range (A˚) 50.0,3.1 (3.2,3.1)
Completeness (%) 94.4 (90.0)
Rmerge (%)* 18.8 (52.0)
I/sigma 6.4 (2.2)
Space group P21
Unit cell parameters a = 27.7 A˚, b = 237.9 A˚, c = 94.3 A˚
a= 90u, b= 110.3u, c= 90u
Refinement statistics
Resolution range (A˚) 40.3,3.1
Number of reflections 48,932
R/Rfree (%)** 23.8/28.3
r.m.s. deviation
bonds (A˚) 0.013
angles (u) 1.94
# of water molecules 11
Average B (A˚2) 22.1
Ramachandran statistics (%)***
Favoured 81.1
Allowed 17.4
Outlier 1.5
*Rmerge =S|I - ,I.|/S,I., where I and ,I. are the measured and averaged
intensities of multiple measurements of the same reflection, respectively. The
summation is over all the observed reflections.
**R =S|Fo – Fc|/S|Fo| calculated for all observed data. Rfree =S|Fo – Fc|/S|Fo|
calculated for a specified number of randomly chosen reflections that were
excluded from the refinement.
***Calculated using PROCHECK [41].
doi:10.1371/journal.pone.0089803.t002
Figure 3. Sequence alignments and antigenic sites. (A) Sequence
alignments of variable region of GC0587 and GC0757 (upper panel) and
H1 HAs (lower panel). Residues in CDRs are in blue open boxes and
residues that interact with HA are highlighted in blue filled boxes.
Epitopes in H1 HAs are highlighted in pink, and more conserved
residues are highlighted in red. Potential glycosylation sites are
H1-Specific Epitopes in Influenza Virus HA
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between HA and LCDR3 are mainly mediated by Glu115 and
Tyr253 of HA and Glu96 and Tyr99 of Fab (Fig. 4A). In the
Fab0587 complex, the carboxylic group of Glu115 of HA interacts
with the main chain atoms of Glu96 and Val97 and the hydroxyl
group of Tyr99. In contrast, the main chain atoms of Arg113 and
side chain atoms of Tyr253 interact with Glu96 in the Fab0757
complex. The side chain of Glu115 forms hydrogen bonds with
the main chain nitrogen of Val97. In fact, the number of
interactions by LCDR3 in the 757 complex is greater than that in
the 587 complex (Table S1 in File S1).
Third, Arg56 of HCDR2 interacts with the side chain of Lys163
of HA in the Fab0587 complex, while it interacts with the main
chain of Ser164 of HA in the Fab0757 complex (Figure S4 in File
S1). Tyr58 has hydrophobic contacts with Pro118 and the
backbone atom of Tyr59 has hydrophilic interactions with
Ser121 of HA in both complex structures. Fourth, the main
differences between Fab0587 and Fab0757 reside in HCDR3,
where only three residues (Tyr103, Tyr106, and Asp109) are in
common from residues 99 to 110. The side chain of Glu112 of HA
interacts with Thr104 in Fab0587 (Fig. 4B). In contrast, the side
chain of Glu112 of HA interacts with the main chain oxygens of
Tyr103 and Val104 in Fab0757. The interaction between Glu115
of HA and Gln105 of Fab is absent in the Fab0587 complex,
whereas it is present in the Fab0757 complex due to Leu to Gln
mutation. Notably, the side chain of Tyr103 in the Fab0587
complex is in a favourable arrangement for a cation-p interaction
with that of Lys171 of HA, and Lys169 has additional interactions
with the main chain oxygen of Gly102 (Fig. 4C). However, the side
chain of Tyr103 protrudes outside from the surface in the Fab0757
complex, where the cation-p interaction is absent. Both Lys169
and Lys171 are highly conserved among H1 subtype viruses and
adopt distinct conformations in each complex, interacting to
different HCDR3 loop conformations.
Epitope Specificity Based on HA Structures
Both 2009 pdm KR01 HA and 1918 pdm HA exhibit 87%
pairwise sequence identity, showing 20% amino acid difference in
the antigenic sites. However, antigenic and glycosylation patterns
of 2009 pdm HA are rather similar to those of 1918 pdm HA
[14]. In the Fab0587 complex, the presence of Pro101 in HCDR3
may play an important role in stabilizing the protrusion of Tyr103
(Fig. 4C). Lys171 of HA is consequently able to make a cation-p
interaction with Tyr103. In contrast, the presence of Gly101 in
HCDR3 in the Fab0757 complex creates a space for the side chain
of Lys169 of HA to occupy, and the cation-p interaction is absent.
When the structures of KR01 HA and 1918 pdm HA are
superimposed, the side chains of Lys172(Lys169) and
highlighted in green. (B) Surface representations of KR01 HAs (gray) and
Fab fragments (dark blue and light blue for H-chain and L-chain,
respectively). Antigenic sites are colored in red for highly conserved
residues and pink for moderately conserved residues. Amino acid
residues involved in the interactions between KR01 HA and Fab0587 are
colored in blue and slate. Insets are surface charge representations with
contours from 210 (red) to+10 (blue) kT through 0 (white). (C) Detailed
interactions of HA with Fab0587. HA and Fab are colored in orange and
blue, respectively. Residues that contribute to the interactions are
represented as stick models. LCDR1 and LCDR3 are colored in purple
and green, respectively (upper panel), and HCDR2 and HCDR3 are
colored in magenta and cyan, respectively (lower panel). (D) Residues
found at other structurally characterized antibody complexes are
colored in yellow, those at both Fab0587 and other antibody complexes
are in orange, and those against GC0587 are in red. Classical antigenic
sites are colored in light pink (Ca, Cb, Sa, and Sb) and those at both
Fab0587 antigenic sites are in pink.
doi:10.1371/journal.pone.0089803.g003
Figure 4. Comparison of Fab binding sites. Residues involved in
interactions between HA and Fab0587 are represented as a ball-and-
H1-Specific Epitopes in Influenza Virus HA
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Lys174(Lys171) of 1918 pdm HA are close to interact with
Glu112. In the Fab0587 complex, however, they would not be
compatible with the protruding conformation of HCDR3, whereas
they can make their conformations complementary to HCDR3 in
the Fab0757 complex. Our results thus suggest that the
conformation of the HCDR3 backbone in the Fab0587 complex
is too close to interact with 1918 pdm HA, causing steric
hindrance. Tyr103 and Thr104 form hydrogen bonds with
Glu96 of LCDR3. In contrast, Gln105 in Fab757 interacts with
Glu96 of LCDR3 (Fig. 4C, lower panel). These interactions
contribute to distinguished conformations between Fab0587 and
Fab0757 complexes. Overall, our results strongly suggest that
residues Ser110-Glu115, Lys169-Lys171, and Tyr253 of HA
provide a H1-specific epitope and both HCDR3 and LCDR3
make major contributions to antibody-antigen interactions to
achieve the epitope specificity.
Discussion
Implication of KR01 HA-Fab Complexes
The most effective way to protect against influenza virus
infection is through vaccination. However, a good match between
circulating strains and the isolates included in the vaccine is often
difficult to attain due to rapid antigenic drift to evade existing
antibody responses [32]. The introduction of 2009 pdm influenza
virus into the human population re-emphasized the need for a
systematic approach to assessing immunogenic epitopes. A typical
binding of antibodies to variable positions at the epitope due to
antigenic drift renders them largely strain specific and susceptible
to antigenic escape.
GC0587 and GC0757 share common epitopes that are
conserved in H1N1 strains, except for 1918 pdm virus. The
structural features of the complexes provided a critical under-
standing of how antibodies with subtype specificity can distinguish
antigenic determinants. It was previously reported that CH65
which binds to receptor binding pocket of HA cross-neutralizes an
unusually large subset of H1N1 viruses using five of the six CDR
loops [23]. Of 27 contact residues of the HA-Fab0587 complex
structure, 7 core residues are .99% conserved across human H1
HA viruses: Glu112, Glu115, Pro118, Ser121, Lys163, Lys169,
and Lys171. In particular, the conserved amino acid residues
Glu112 and Glu115 have close contacts with HCDR3 and
LCDR3, respectively. They thus comprise the epitopes recognized
by both GC0587 and GC0757 and are different from the known
antigenic sites, Sa, Sb, Ca, and Cb, exhibiting a distinct epitope in
the head region for H1 subtype specificity. Notably, the new
epitope is highly conserved among H1 influenza variants and has
no glycosylation sites. It also reveals common features of interface
contacts including HCDR3 and LCDR3, which explains that
GC0587 and GC0757 have a broad cross-reactivity among H1
subtypes. H1 subtype-specific epitopes were recently identified by
peptide scanning using libraries of overlapping peptides [33]. A
new epitope (residues 58–72) was close to the link between the
stem and globular head regions, which is highly conserved.
Another epitope-mimic peptide (residues 158–182) that was highly
immunogenic is close to what we observed in this study, where
residues from Lys169 to Lys170 are included in the epitope mimic
peptide. Taken together, unlike known H1 antigenic sites, the b-
strands constituted by Ser110-Glu115 and Lys169-Lys170 formed
H1 epitopes with distinct conformations from those of H3 HA.
The backbone conformation of H1 HA was significantly different
from that of H2, H5 and H3 HAs in roughly increasing order of
deviation (Figure S4 in File S1). The 16 subtypes of HA segregate
into two groups [7], where H1 and H3 belong to group 1 and 2,
respectively. This epitope region was the most different in various
subtype HAs and makes the largest difference in conformation
between H1 and H3 HAs.
Moreover, the main differences between Fab0587 and Fab0757
complex structures reside mainly in HCDR3 and LCDR3,
although some conformational differences are found in HCDR2
and LCDR1. It was shown that the antigenic pattern of 2009 pdm
HA is similar to those of 1918 pdm HA [14]. The interaction of
Lys172(Lys169) and Lys174(Lys171) with Glu112 of 1918 pdm
HA is not compatible with the protruding conformation of
HCDR3 of Fab0587, whereas it can be compatible with that of
Fab0757. Thus, Glu112, Lys169, and Lys171 are important
epitope residues to differentiate Fab0587 and Fab0757, and
HCDR3 and LCDR3 make major contributions to antibody-
antigen interactions to achieve epitope specificity. The unpredict-
ability of the occurrence of influenza epidemics is originated from
the wide range of antigenically different viruses, and the structural
features of the complexes provide an understanding of how
antibodies with subtype specificity can distinguish antigenic
determinants. The results of our complex structures of a
neutralizing monoclonal antibody with H1 subtype specificity
can be used for potential use against influenza A viruses.
Materials and Methods
Preparation of Cells
MDCK cells (American Tissue Culture Type CCL-31) and
Vero cells (Korean Cell Line Bank 10081) were grown in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, USA)
supplemented with 10% fetal bovine serum (FBS, Sigma, USA),
1% glutamine, and 1% penicillin-streptomycin (PS, Invitrogen,
USA) under 5% CO2 humidified atmosphere at 37uC. The cells
were passed for no more than 20 passages.
Virus Collection and Assays
H1N1 A/Thailand/CU44/2006 (CU44), A/Brisbane/59/2007
(BR59) and 2009 pdm KR01, and H3N2 A/Gyeongnam/684/
2006 (Gy684) were propagated in MDCK or Vero cells with
DMEM supplemented with 0.2% BSA, 25 mM HEPES, 1%
glutamine, 1% penicillin-streptomycin, and 2 mg/ml of L-
(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK)-treated
trypsin (from bovine pancreas, PIERCE, USA) under 5% CO2
atmosphere at 37uC for 2–3 days. Virus titer was determined by
using plaque assay (PFU/ml), TCID50, and hemagglutination
assay and virus stocks were stored in deep freezer (277uC) until
experiments.
Immunization and Production of Monoclonal Antibodies
Four-week old female Balb/c mice were immunized by
intraperitoneal injection of 100 mg of 2009 pdm H1N1 A/
California/04/2009 (CA04) vaccine dissolved in 100 ml PBS plus
complete Freund’s adjuvant (Sigma-Aldrich, St Louis, MO, USA).
Boost immunizations were given at 3 weeks post-vaccination.
Animals were maintained and treated according to the Green
Cross guidelines. All experiments in mice were approved by the
stick model and hydrophilic interactions as dotted line. Residues of HA
in complex with Fab0587 are colored in orange and H-chains of
Fab0587 and Fab0757 are in dark and light blue, respectively. (A)
Comparison of LCDR3, (B) HCDR3. (C) Superposition of KR01 HA bound
to Fab0587 (magenta), KR01 HA bound to Fab0757 (dark gray), free
KR01 HA (yellow), 1918 pdm HA (green), Fab0587 (purple), and Fab0757
(light teal). Surface representations are based on the KR01HA-Fab0587
complex structure.
doi:10.1371/journal.pone.0089803.g004
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Institutional Animal Care and Use Committee (IACUC) of the
Green Cross.
Mouse spleen cells collected at 4 days after the 5th immuni-
zation boost with vaccine were fused to the sp2/0 myeloma cells.
Fused cells were distributed over 96 well tissue culture plates at
2,000 cells per well in complete DMEM medium containing
100 mM hypoxanthine, 0.4 mM aminopterin, and 16 mM thymi-
dine (HAT). With weekly replacement of medium, antibody-
producing cells were screened by ELISA and subcloned by
limiting dilution. Ferret anti-BR59 whole serum was used as 1/50
dilution and monoclonal antibody was used at a final concentra-
tion of 80 mg/ml. Positive clones were checked for isotype by using
Iso-GoldTM rapid mouse-monoclonal isotyping test kit (Bioassay
Works, Ijamsville, MD, USA) as described in the manufacturer’s
protocol.
Microtiter plates were coated with 100 ml of vaccine or its
equivalent HA (5 mg/ml) diluted in PBS per well at 4uC overnight,
and blocked with PBS containing 1% BSA and 0.05% Tween 20
at room temperature for 1 hr. One hundred ml of hybridoma
supernatant or purified antibodies per well was transferred into the
ELISA plates. Binding reaction was carried out at room
temperature for 2 hrs. Plates were subsequently washed four
times with PBS containing 0.05% Tween 20, and 100 ml of HRP-
conjugated goat anti-human Fab (Sigma-Aldrich, St Louis, MO,
USA) diluted 1:10,000 in PBS was added, and reactions were
carried out at room temperature for 1 hr. Plates were washed four
times, and 100 ml of tetramethyl benzidine substrate (KPL,
Gaithersburg, MD, USA) per well was added. The absorbance
was determined at 490 nm.
Cloning and Baculovirus Production
HA gene were cloned downstream of the gp67 secretion signal
sequence of the transfer vector pAcGP67A (BD Biosciences, MA,
USA). Based on H3 numbering, the corresponding residues were
11–329 (1–327) (HA1) and 330–506 (1–176) (HA2), with a
thrombin cleavage site, foldon region, and 6xHis-tag downstream
of the HA gene sequence [34]. The recombinant HA proteins
contained additional plasmid-encoded residues (ADPG for sea-
sonal H1 and ADPGYLLEF for 2009 pdm H1) at their N-
terminus and RSLVPR at the C-terminus. All sequences were
confirmed by automated sequencing (Macrogen, Seoul, Korea).
Plasmids encoding each HA gene were amplified in E. coli strain
DH5a and then used to co-transfect Sf9 cells along with linearized
baculovirus chromosomal DNA (BaculoGold; BD Biosciences,
MA, USA) by the calcium transfection method. The virus was
harvested after 5 days, and transfection efficiency was confirmed
by PCR after extraction of DNA from 400 ml of virus (cell
supernatant). This original virus stock was amplified through
repeated rounds of infection.
Protein Expression and Purification
Baculovirus containing HA gene was used to infect suspension
cultures of Hi5 cells. After 3,4 days at 28uC, the culture medium
was harvested and applied to a Ni-NTA column equilibrated with
working buffer (20 mM Tris-HCl, pH 8.0, 200 mM NaCl). The
column was washed with buffer containing 50 mM imidazole and
precursor HA protein was eluted in an imidazole gradient, which
was dialysed against 10 mM Tris-HCl (pH 8.0) and 50 mM NaCl,
and hydrolysed by thrombin for 12 hrs at 4uC for removal of the
foldon region and 6xHis-tag. The reaction was halted by the
addition of 1 mM phenylmethylsulphonyl fluoride, and the active
form of HA was purified by Mono Q ion-exchange chromatog-
raphy and Superdex 200HR size exclusion chromatography.
The neutralizing antibodies with activity against H1 subtype
influenza viruses, GC0346, GC0587, GC0757, and GC1517, were
purified using protein A columns (GE Healthcare, Piscataway, NJ,
USA). Each was then treated with papain at a ratio of 1:50 (w/w)
for 2 hrs in PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4,
137 mM NaCl, 2.7 mM KCl, and pH 7.4) with 5 mM EDTA and
5 mM L-cysteine, and the reaction was stopped with 30 mM
crystalline iodoacetamide. The solution containing Fab fragments
was dialyzed against the PBS buffer and applied to protein A
column. The unbound fraction was purified by Superdex 200HR
gel filtration chromatography. It was then mixed with HA at a
1:1.5 molar ratio for 12 hr incubation, and the complex was
further purified by Superdex 200HR gel filtration chromatogra-
phy.
Crystallization and Data Collection
The complex of HA and Fab0587 was screened by hanging
drop vapour diffusion method. 1 ml of the 10 mg/ml complex in
20 mM Tri-HCl (pH 8.0) and 50 mM NaCl was mixed with 1 ml
of screening solution of 20% PEG3350 and 200 mM potassium
iodide and incubated at 4uC. After one week, small rhombic
crystals were obtained. Diffraction data were collected with the
crystals flash-cooled at 100 K in a stream of liquid N2 in the
mother liquor containing 22% glycerol using synchrotron radia-
tion sources at beamlines 5C at Pohang Light Source (Pohang,
Korea). The crystals of HA-Fab0587 diffracted to 2.8 A˚ resolu-
tion, which belong to space group P21 with unit cell dimensions
a = 72.8 A˚, b = 237.8 A˚, c = 94.2 A˚, a= 90u, b= 110.3u, c= 90u
(Table 1). All data were processed and scaled using the HKL2000
program [35].
Structure Solution and Refinement
The crystal structure of KR01 HA-Fab0587 was solved by
molecular replacement using the KR01 HA-Fab0757 structure
(PDB ID 4F15) as a template using CCP4 [36] or PHENIX [37].
The solvent content of HA-Fab0587 crystals were 65.2% using
Matthews coefficient of 2.87, indicating that four complexes of HA
and Fab fragments exist in the asymmetric unit. After the
substitution of the Fab sequences with those of Fab0587 and
manual adjustment using Coot [38], the initial solution was
optimized by rigid body refinement, which produced interpretable
electron density maps for the overall structure. Manual adjustment
of the backbone and side chains was conducted and crystallo-
graphic refinement was carried out using the program PHENIX
[37]. Difference Fourier maps, 2|Fo|-|Fc| and |Fo|-|Fc|, have
been used to model the active site or loop regions. After a few
rounds of model rebuilding, water molecules were added using the
Fo-Fc map peaks above 3.0s, if the B factors were below 50 A˚
2
after refinement. The Rfree value was used as an indicator to
validate the water picking and refinement procedure and to guard
against possible overfitting of the data [39]. R factor and R free
were 0.23 and 0.27, respectively, after several round of refinement
using PHENIX program. Data quality and refinement statistics for
both Fab0587-HA and Fab0757-HA complexes are presented in
Table 2. Stereochemical analysis of all refined structures using
PROCHECK [40]. showed that there were 1.6% of outliers in the
Ramachandran plot with 81.2% of favoured region among the
2,577 residues for HA-Fab0587. These outliers were located in the
disordered loop regions.
Accession Number
Data deposition2The atomic coordinates and structure factors
have been deposited in the Protein Data Bank (www.rcsb.org)
with PDB ID code 4LVH for H1N1 HA-Fab0587 structure.
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Supporting Information
File S1 Supporting Information. Table S1, Interactions
between KR01 HA and Fab fragments. Figure S1, Crystal packing
in the KR01 HA-Fab0587 complex. The head domain (HA1) of
HA is shown in red color and Fab in blue in one complex, and
others are in green. The stem regions (HA2) of HA could not be
modeled due to weak electron density, but there are empty space
for them. A partial model for HA2 is shown in the lower panel.
Figure S2, Sequence alignments of HAs. Epitopes in H1 HAs are
highlighted in red, and more conserved residues are highlighted in
more red. Residues in other HA those are same with that of
epitope in H1 HAs are indicated by red boxes. Potential
glycosylation sites are highlighted in green. Figure S3, LCDR1
at Fab binding site. Residues involved in interactions between HA
and Fab0587 are represented as a ball-and-stick model and
hydrophilic interactions as dotted line. Residues of HA in complex
with Fab0587 are colored in orange and H-chains of Fab0587 and
Fab0757 are in dark and light blue, respectively. Figure S4,
HCDR2 at Fab binding site. Residues involved in interactions
between HA and Fab0587 are represented as a ball-and-stick
model and hydrophilic interactions as dotted line. Residues of HA
in complex with Fab0587 are colored in orange and H-chains of
Fab0587 and Fab0757 are in dark and light blue, respectively.
Figure S5, Comparison of novel H1 specific epitope regions
among different subtypes. Superposition of the novel epitope
conformations of H1 (blue), H2 (gray), H3 (dark gray), and H5
(green) HA. RMSD was calculated based on secondary structure
matching of head domain of H1 with that of other subtypes, to
show 1.19, 1.68 and 1.34 A˚ for H2, H3 and H5, respectively.
(DOCX)
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